Sheinbaum says US 'won't' attack cartels on Mexican soil Zetagen Therapeutics, a privately held clinical-stage biopharmaceutical company pioneering first-of-its-kind targeted therapies for both ...
Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...
AIM ImmunoTech Inc. (NYSE American: AIM) ('AIM” or the 'Company”) today announced that data from the completed Phase 2 cisplatin-resistant advanced recurrent ovarian cancer clinical study utilizing ...
Vortex Energy Corp. (CSE: VRTX) (OTC: VTECF) (FSE: AA3) (“Vortex” or the “Company”) is pleased to announce that the University of ...
AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback